List of SBIR/STTR awards granted to Eldec Pharmaceuticals, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Eldec Pharmaceuticals, Inc. in August, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AI162083-01A1 | Phase I | 300,000 | August 23, 2022 | |||||||
A SBIR Phase II contract was awarded to Eldec Pharmaceuticals, Inc. in August, 2022 for $999,919.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HL165964-01 | Phase II | 999,919 | August 10, 2022 | |||||||
A STTR Phase II contract was awarded to Eldec Pharmaceuticals, Inc. in July, 2021 for $999,840.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42AI155107-02 | Phase II | 999,840 | July 19, 2021 | |||||||
A STTR Phase I contract was awarded to Eldec Pharmaceuticals, Inc. in June, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42AI155107-01 | Phase I | 300,000 | June 22, 2020 | |||||||
A SBIR Phase I contract was awarded to Eldec Pharmaceuticals, Inc. in July, 2018 for $224,865.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL144290-01 | Phase I | 224,865 | July 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Eldec Pharmaceuticals, Inc. in May, 2023 for $259,121.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI174395-01 | Phase I | 259,121 | May 3, 2023 |
